Dapagliflozin A Multi-Targeted Therapy for Diabetes, Heart Failure, and Kidney Disease Introduction Dapagliflozin is a sodium-glucose cotransporter-2 (SGLT2) inhibitor developed primarily for managing type 2 diabetes mellitus (T2DM). However, its therapeutic use has expanded significantly due to demonstrated benefits in heart failure […]